| AD | Autoimmune disease |
| AF | Atrial fibrillation |
| APC | Autologous platelets concentrates |
| A-PRF | Advanced platelet-rich fibrin |
| AT-SVF | Adipose-tissue stromal vascular fraction |
| BMP2 | Bone morphogenetic protein 2 |
| BPs | Bisphosphonates |
| BRONJ | Bisphosphonate-related osteonecrosis of the jaw |
| CGF | Concentrated growth factor |
| CHX | Chlorhexidine |
| CS | Case Series |
| DM | Diabetes |
| HCL | Hypercholesterolemia |
| HF | Heart Failure |
| HTA | Hypertension |
| i-PRF | Injectable platelet-rich fibrin |
| IV | Intravenous |
| L-PRF | Leukocyte-platelet rich fibrin |
| L-PRP | Leukocyte- and platelet-rich plasma |
| MI | Myocardial infarction |
| Min | Minutes |
| MIU | Million international units |
| MRONJ | Medication-related osteonecrosis of the jaw |
| MTX | Methotrexate |
| N.R. | Not reported |
| ONJ | Osteonecrosis of jaw |
| PDGF | Platelet-derived growth factor |
| PO | Per os |
| PPP | Platelet-poor plasma |
| PRF | Platelet-rich fibrin |
| PRGF | Plasma rich in growth factors |
| PRP | Platelet-rich plasma |
| RCT | Randomized control trial |
| RD | Rheumatoid disease |
| RF | Renal Failure |
| rpm | Rotations per minute |
| SC | Subcutaneous |
| SVF | Stromal vascular fraction |